Introduction to Arthrosamid Injections
Arthrosamid is an injectable gel made from a hydrophilic polyacrylamide hydrogel, used to treat knee osteoarthritis—a condition where the cartilage in the knee gradually wears away, causing pain and stiffness. When injected directly into the knee joint, Arthrosamid acts as a cushion and lubricant, helping to reduce pain and improve movement. It is often considered when other non-surgical treatments, like physiotherapy or painkillers, haven’t provided enough relief.
While Arthrosamid presents some promising benefits, it’s important to remember that no medical procedure is without risks. Understanding both the advantages and potential downsides will help you make an informed choice about your treatment. This article offers a clear, balanced look at the risks and safety of Arthrosamid injections so you know what to expect.
Known Risks and Side Effects According to Clinical Evidence
Research shows that most people tolerate Arthrosamid injections well. A recent review noted that “Injection of PAAG hydrogel intraarticularly into the knee has been shown to be safe with no long-lasting adverse events reported.” Nonetheless, as with any injection, side effects can happen.
Commonly, patients may experience some temporary pain, swelling, or mild inflammation around the injection site. These effects are generally short-lived and stem from the body’s natural response to the injection and the gel’s presence in the joint. Usually, such symptoms improve within a few days without needing extra treatment.
More rarely, serious complications can occur, such as joint infections, bleeding inside the joint, allergic reactions, or lumps forming around the injection area. Although uncommon, these risks require awareness, especially for those with certain health conditions that might increase their vulnerability.
Long-term safety data remains limited, but so far, studies confirm “no long-lasting adverse events reported.” Additionally, laboratory tests have shown that the gel itself does not cause nerve cell damage in vitro: “2.5 iPAAG demonstrates no apparent in vitro neurotoxic or cytotoxic effects in human iCell® GlutaNeurons at concentrations up to 20% for 96 hours.”
Factors That May Increase Risk
Certain individuals may be more likely to experience complications from Arthrosamid treatment. For example, people with weakened immune systems—whether due to autoimmune conditions or medication—may be more prone to infections. Those with diabetes or bleeding disorders should also exercise caution, as these conditions can affect healing.
If you have any known allergies to injectable products or components in Arthrosamid, it is vital to inform your healthcare provider. Additionally, if you are taking blood thinners or have an active infection, these factors must be shared before treatment as they can elevate risk.
Severe damage or deformities in the knee joint may also affect how safely and effectively Arthrosamid works. In such cases, your doctor will perform detailed assessments including physical exams and scans to determine if this treatment is suitable.
Free non-medical discussion
Not sure what to do next?
Information only · No medical advice or diagnosis.
Comparing Arthrosamid Risks to Other Knee Injection Options
Arthrosamid is one among several injectable therapies available to ease knee osteoarthritis symptoms, alongside corticosteroids and hyaluronic acid.
A recent study assessing these treatments found that “iPAAG offers comparable short-term efficacy and modest advantage at 6 months. However, long-term superiority is limited.” The same study noted that iPAAG showed the highest rates of patient satisfaction over 3, 6, and 12 months, though differences between treatments were not statistically significant. This means Arthrosamid can be a good option for medium-term relief, though its long-term benefits over others are still uncertain.
Another review highlighted that in one randomised control trial, Arthrosamid data was “numerically superior compared to hyaluronic acid,” pointing to promising effectiveness alongside a safety profile similar to other injectables. Corticosteroids usually provide quick relief but can harm cartilage if used too often. Hyaluronic acid injections aim to restore natural lubrication and tend to have mild side effects, though how well they work varies between individuals.
Thanks to its gel’s unique properties, Arthrosamid may cushion the joint for a longer time, potentially reducing how often injections are needed. In summary, the literature states, “PAAG hydrogel seems to be an efficacious and safe treatment option for knee OA and provides positive results for at least 2 years.”
Minimising Risks: What to Discuss with Your Healthcare Provider
Before deciding on Arthrosamid injections, it’s important to have an open, thorough conversation with your healthcare professional. Ask about their experience with this procedure and what steps they take to reduce any risks, especially infection.
It’s helpful to know what symptoms after the injection would require medical attention and what ongoing care or follow-up appointments are planned.
Medical teams usually take careful precautions including sterile injection methods, pre-treatment screening for infections or allergies, and close monitoring after the procedure.
You also play a key role. Following your post-injection care instructions carefully, reporting any unusual pain or swelling straight away, and keeping all follow-up visits will help ensure the best outcome and early detection of any potential problems.
Conclusion
Arthrosamid injections offer an encouraging option for people with knee osteoarthritis, with potential to reduce pain and improve joint function. While most side effects tend to be mild and temporary, some rare but serious complications do exist and should be taken seriously.
Understanding both the benefits and possible risks, and discussing them openly with your healthcare provider, is key to making the best choice for your individual needs. As research emphasises, “PAAG hydrogel seems to be an efficacious and safe treatment option for knee OA and provides positive results for at least 2 years.”
If you are considering Arthrosamid, speaking with a knowledgeable health professional will help guide your decision and support safe, effective care for your knee health.
References
- Cole, A., Maulana, R., Whitehead, J., & Lee, P. (2022). A Systematic Review of the Novel Compound Arthrosamid Polyacrylamide (PAAG) Hydrogel for Treatment of Knee Osteoarthritis. Medical Research Archives, 10(8). https://doi.org/10.18103/mra.v10i8.2950
- Aykaç, B., Dinç, M., Nar, Ö. O., Karasu, R., & Bayrak, H. Ç. (2025). Comparative efficacy of polyacrylamide hydrogel versus hyaluronic acid and corticosteroids in knee osteoarthritis: A retrospective cohort study. Medicine, 104(23), e44655. https://doi.org/10.1097/MD.0000000000044655
- Walmod, P. S., Kusk, P., Jøhnk, N., Ankorina-Stark, I., & Essex, A. (2025). An injectable 2.5% cross-linked polyacrylamide hydrogel (2.5 iPAAG) demonstrates no neurotoxicity in human induced pluripotent stem cells-derived iCell® GlutaNeurons. Frontiers in Toxicology. https://doi.org/10.3389/ftox.2025.1585430
Frequently Asked Questions
- Arthrosamid® injections provide pain relief and improved knee mobility for osteoarthritis patients. AMSK Clinic’s team uses the latest clinical evidence and advanced injection techniques, offering patients a non-surgical option when other conservative treatments have not achieved adequate results.
- Arthrosamid® injections are generally well tolerated, with most side effects being mild and short-lived. At AMSK Clinic, strict sterile procedures, thorough screening for allergies or infections, and careful post-injection monitoring are used to minimise risks and promote safe recovery.
- Individuals with weakened immune systems, diabetes, bleeding disorders, or known allergies to injectable products should have special assessments at AMSK Clinic. The clinic’s tailored approach ensures each patient’s risks are fully evaluated before proceeding with Arthrosamid® treatment.
- Clinical studies show Arthrosamid® has similar or slightly better medium-term results compared to other injectables. Patients treated at AMSK Clinic benefit from expert guidance to choose the most suitable therapy based on their medical history and treatment goals.
- AMSK Clinic supports patients with clear post-injection care instructions, timely follow-up appointments, and direct access to expert advice. This comprehensive aftercare enables patients to manage any concerns and ensures the best possible outcome following Arthrosamid® treatment.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of AMSK. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. AMSK accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
